Bright Minds Biosciences Statistics
NASDAQ: DRUGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
55.17+3.17 (+6.10%)
Market open · Delayed 15 min · as of Oct 9, 2:33 PM ET
Bright Minds Biosciences by the numbers
Bright Minds Biosciences has a market capitalization of $544.2 million based on 9.86M shares outstanding. With trailing EPS of $-2.05, Bright Minds Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.1% below its 50-day average and 27.2% below its 200-day average.
Average daily trading volume is 159.01K shares, or about $8.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DRUG valuation vs. peer median
| Metric | DRUG | Peer median | Difference |
|---|---|---|---|
| Market cap | $544.20M | $515.11M | +6% |
| Avg. volume | 159.01K | 652.53K | -76% |
Peer median across 8 companies: EOLS, ALT, CTNM, OCS, ARVN, PBYI, MPLT, NGNE.
Valuation
- Market cap
- $544.20M
- EPS (TTM)
- $-2.05
- Shares outstanding
- 9.86M
Price and trading
- Previous close
- 52.00
- Open
- 51.91
- Day range
- 51.91 – 55.29
- 52-week range
- 47.23 – 123.75
- 52-week change
- -5.80%
- Beta
- —
- Volume
- 58.57K
- Average volume
- 159.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 17, 2026
Additional statistics
- Market Cap
- 544.20M
- Forward Pe
- -9.60
- Eps
- -2.05
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 123.75
- Week52 Low
- 47.23
- Avg Volume
- 159.01K
- Shares Outstanding
- 9.86M
- Ma50
- 67.35
- Ma200
- 75.82
- Earnings Date
- Aug 17, 2026
- Pct From52w High
- -55.42%
- Pct From52w Low
- 16.81%